Advertisement
Singapore markets close in 43 minutes

  • Straits Times Index

    3,277.85
    -9.90 (-0.30%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,675.82
    +391.28 (+2.26%)
     

  • FTSE 100

    8,117.49
    +38.63 (+0.48%)
     

  • Bitcoin USD

    64,427.80
    +356.75 (+0.56%)
     

  • CMC Crypto 200

    1,387.54
    -9.00 (-0.64%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • Dow

    38,085.80
    -375.12 (-0.98%)
     

  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     

  • Gold

    2,359.10
    +16.60 (+0.71%)
     

  • Crude Oil

    84.00
    +0.43 (+0.51%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • FTSE Bursa Malaysia

    1,574.35
    +5.10 (+0.33%)
     

  • Jakarta Composite Index

    7,058.76
    -96.54 (-1.35%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Company News for Jul 8, 2020

Zacks Equity Research
·1-min read

  • Walmart Inc.'s WMT shares surged 6.8% following the news that the company will unveil a new subscription program for $98 per year to provide various services to its members.

  • Shares of Novavax Inc. NVAX soared 31.6% after it awarded $1.6 by the U.S. government to expedite testing, manufacturing and commercialization of a potential COVID-19 vaccine.

  • Shares of DocuSign Inc. DOCU surged 3.7% after the company acquired Liveoak Tehnologies for $38 million to diversify on online notarization space.

  • Regeneron Pharmaceuticals Inc.'s REGN shares gained 2.2% after it received $450 million from the U.S. government to produce and supply its still investigational drug for COVID-19 treatment.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report
 
Walmart Inc. (WMT) : Free Stock Analysis Report
 
Novavax, Inc. (NVAX) : Free Stock Analysis Report
 
DocuSign Inc. (DOCU) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research